This clinical trial is focused on patients undergoing total joint replacement (TJR) surgery, which involves replacing a damaged joint, such as a hip or knee, with an artificial one. The study aims to explore new treatments to prevent infections after these surgeries. Infections can be a serious complication, sometimes requiring additional surgery to address them. The trial will compare different solutions used during surgery to see if they can reduce the risk of infection within 12 months after the procedure.
Participants in the study will receive one of several treatments. One group will receive a solution containing povidone, a type of antiseptic, while another group will receive a solution with chlorhexidine, which is also used to kill bacteria. There is also a group that will receive vancomycin, an antibiotic, applied locally during surgery. These treatments will be compared to a standard saline solution, which is a simple saltwater solution commonly used in medical settings. The purpose is to determine if these treatments can lower the chances of needing another surgery due to infection.
The study will follow participants for up to 12 months after their surgery to monitor for any infections that might require reoperation. By comparing the outcomes of the different treatment groups, researchers hope to find more effective ways to prevent infections in patients undergoing TJR surgery. This could lead to improved recovery and fewer complications for future patients undergoing similar procedures.



Spain